Does comorbid subthreshold anxiety predict treatment response in depression? Results from a naturalistic cohort study (the CRESCEND study)

Journal of Affective Disorders

Volumn 152-154, Issue 1, 2014, Pages 352-359

  Seo, Ho Jun ^a,g   Song, Hoo Rim ^b,g   Jeong, Seunghee ^c,g   Kim, Jung Bum ^d,g   Lee, Min Soo ^e,g   Kim, Jae Min ^f,g   Yim, Hyeon Woo ^c,g   Jun, Tae Youn ^b,g  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Keimyung University   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Chonnam National University Medical School   (South Korea)

^g Clinical Research Center for Depression   (South Korea)

Author keywords

Anxious depression; Comorbid anxiety; Predictor; Treatment outcome

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROMAZEPAM; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MILNACIPRAN; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZOLPIDEM;

ADULT; ANXIETY; ANXIETY DISORDER; ANXIOUS DEPRESSION; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NATURALISTIC INQUIRY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REMISSION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT RESPONSE; COMPLICATION; DEPRESSIVE DISORDER; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; TIME; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84889097177     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.09.037     Document Type: Article

References (45)

1. A.C. Altamura, C. Montresor, D. Salvadori, and E. Mundo Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study International Journal of Neuropsychopharmacology 7 2004 481 487
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Fourth Edition 1994 American Psychiatric Press Washington, DC
3. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder (revision) American Journal of Psychiatry 157 Suppl 4 2000 1 45
4. J. Angst, and A. Dobler-Mikola The Zurich study. VI. A continuum from depression to anxiety disorders? European Archives of Psychiatry and Neurological Sciences 235 1985 179 186
5. D.S. Baldwin, A.K. Huusom, and E. Maehlum Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study British Journal of Psychiatry 189 2006 264 272
6. B. Bandelow, H.F. Andersen, and O.T. Dolberg Escitalopram in the treatment of anxiety symptoms associated with depression Depression and Anxiety 24 2007 53 61
7. L. Besiroglu, F. Uguz, M. Saglam, M.Y. Agargun, and A.S. Cilli Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder Journal of Affective Disorders 102 2007 73 79
8. A. Bittner, R.D. Goodwin, H.U. Wittchen, K. Beesdo, M. Hofler, and R. Lieb What characteristics of primary anxiety disorders predict subsequent major depressive disorder? Journal of Clinical Psychiatry 65 2004 618 626 (quiz 730)
9. A. Cipriani, T.A. Furukawa, G. Salanti, J.R. Geddes, J.P. Higgins, R. Churchill, N. Watanabe, A. Nakagawa, I.M. Omori, H. McGuire, M. Tansella, and C. Barbui Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 2009 746 758
10. P.J. Clayton, W.M. Grove, W. Coryell, M. Keller, R. Hirschfeld, and J. Fawcett Follow-up and family study of anxious depression American Journal of Psychiatry 148 1991 1512 1517
11. âD report American Journal of Psychiatry 165 2008 342 351
12. M. Fava, L.A. Uebelacker, J.E. Alpert, A.A. Nierenberg, J.A. Pava, and J.F. Rosenbaum Major depressive subtypes and treatment response Biological Psychiatry 42 1997 568 576
13. M.B. First, R.L. Spitzer, M. Gibbon, and J.B. Williams User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders Research Version (SCID-I) 1996 New York State Psychiatric Institute, Biometrics Research New York, NY
14. J.D. Ford, J.D. Elhai, K.J. Ruggiero, and B.C. Frueh Refining posttraumatic stress disorder diagnosis: evaluation of symptom criteria with the National Survey of Adolescents Journal of Clinical Psychiatry 70 2009 748 755
15. B.N. Gaynes, K.M. Magruder, B.J. Burns, H.R. Wagner, K.S. Yarnall, and W.E. Broadhead Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? General Hospital Psychiatry 21 1999 158 167
16. R.D. Goodwin, R. Lieb, M. Hoefler, H. Pfister, A. Bittner, K. Beesdo, and H.U. Wittchen Panic attack as a risk factor for severe psychopathology American Journal of Psychiatry 161 2004 2207 2214
17. W. Guy ECDEU Assessment Manual for Psychopharmacology Revised 1976 National Institute of Mental Health Rockville, MD
18. M. Hamilton The assessment of anxiety states by rating British Journal of Medical Psychology 32 1959 50 55
19. J.M. Kim, S.W. Kim, R. Stewart, S.Y. Kim, J.S. Yoon, S.W. Jung, M.S. Lee, H.W. Yim, and T.Y. Jun Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study Human Psychopharmacology 26 2011 41 50
20. T.S. Kim, S.H. Jeong, J.B. Kim, M.S. Lee, J.M. Kim, H.W. Yim, and T.Y. Jun The clinical research center for depression study: baseline characteristics of a Korean long-term hospital-based observational collaborative prospective cohort study Psychiatry Investigation 8 2011 1 8
21. J.M. Kim, R. Stewart, N. Glozier, M. Prince, S.W. Kim, S.J. Yang, I.S. Shin, and J.S. Yoon Physical health, depression and cognitive function as correlates of disability in an older Korean population International Journal of Geriatric Psychiatry 20 2005 160 167
22. K.R. Krishnan Comorbidity and depression treatment Biological Psychiatry 53 2003 701 706
23. J.Y. Lee, M.J. Cho, and J.S. Kwon Global assessment of functioning scale and social and occupational functioning scale. Korean Journal of Psychopharmacology 17 2006 122 127
24. R.B. Lydiard, and O. Brawman-Mintzer Anxious depression Journal of Clinical Psychiatry 59 Suppl 18 1998 10 17
25. J.C. Nelson Anxious depression and response to treatment American Journal of Psychiatry 165 2008 297 299
26. J.C. Nelson Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials Depression and Anxiety 27 2010 12 18
27. J.C. Nelson, K. Delucchi, and L.S. Schneider Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis International Journal of Geriatric Psychiatry 24 2009 539 544
28. A.A. Nierenberg, J.E. Alpert, J. Pava, J.F. Rosenbaum, and M. Fava Course and treatment of atypical depression Journal of Clinical Psychiatry 59 Suppl 18 1998 5 9
29. M.L. O'Donnell, M. Creamer, and P. Pattison Posttraumatic stress disorder and depression following trauma: understanding comorbidity American Journal of Psychiatry 161 2004 1390 1396
30. G. Parker, K. Wilhelm, P. Mitchell, K. Roy, and D. Hadzi-Pavlovic Subtyping depression: testing algorithms and identification of a tiered model Journal of Nervous and Mental Disease 187 1999 610 617
31. L.C. Quarantini, A.R. Torres, A.S. Sampaio, V. Fossaluza, M.A. Mathis, M.C. do Rosario, L.F. Fontenelle, Y.A. Ferrao, A.V. Cordioli, K. Petribu, A.G. Hounie, E.C. Miguel, R.G. Shavitt, and K.C. Koenen Comorbid major depression in obsessive-compulsive disorder patients Comprehensive Psychiatry 52 2011 386 393
32. K. Rickels, M.H. Pollack, D.E. Feltner, R.B. Lydiard, D.L. Zimbroff, R.J. Bielski, K. Tobias, J.D. Brock, G.L. Zornberg, and A.C. Pande Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam Archives of General Psychiatry 62 2005 1022 1030
33. âD report American Journal of Psychiatry 163 2006 1905 1917
34. J.M. Russell, L.M. Koran, J. Rush, R.M. Hirschfeld, W. Harrison, E.S. Friedman, S. Davis, and M. Keller Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression Depression and Anxiety 13 2001 18 27
35. H.J. Seo, Y.E. Jung, T.S. Kim, J.B. Kim, M.S. Lee, J.M. Kim, H.W. Lim, and T.Y. Jun Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression Journal of Nervous and Mental Disease 199 2011 42 48
36. P.H. Silverstone, and E. Salinas Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder Journal of Clinical Psychiatry 62 2001 523 529
37. P.H. Silverstone, and E. von Studnitz Defining anxious depression: going beyond comorbidity Canadian Journal of Psychiatry 48 2003 675 680
38. C. Stavrakaki, and B. Vargo The relationship of anxiety and depression: a review of the literature British Journal of Psychiatry 149 1986 7 16
39. M.E. Thase, K. Demyttenaere, W.R. Earley, U. Gustafsson, M. Udd, and H. Eriksson Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression Depression and Anxiety 29 2012 574 586
40. âD: implications for clinical practice American Journal of Psychiatry 163 2006 28 40
41. M.H. Trivedi, M.E. Thase, M. Fava, C.J. Nelson, H. Yang, Y. Qi, Q.V. Tran, A. Pikalov, B.X. Carlson, R.N. Marcus, and R.M. Berman Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features Journal of Clinical Psychiatry 69 2008 1928 1936
42. R. Uher, M.Z. Dernovsek, O. Mors, J. Hauser, D. Souery, A. Zobel, W. Maier, N. Henigsberg, P. Kalember, M. Rietschel, A. Placentino, J. Mendlewicz, K.J. Aitchison, P. McGuffin, and A. Farmer Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline Journal of Affective Disorders 132 2011 112 120
43. H.U. Wittchen, R.C. Kessler, H. Pfister, and M. Lieb Why do people with anxiety disorders become depressed? A prospective-longitudinal community study Acta Psychiatrica Scandinavica Suppl 2000 14 23
44. J.S. Yi, S.O. Bae, Y.M. Ahn, D.B. Park, K.S. Noh, H.K. Shin, H.W. Woo, H.S. Lee, S.I. Han, and Y.S. Kim Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS) Journal of Korean Neuropsychiatric Association 44 2005 456 465
45. M. Zimmerman, and J.I. Mattia A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire Archives of General Psychiatry 58 2001 787 794